Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C 1Hepatitis B 1Carcinoma, Hepatocellular 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 16Zidovudine 13Vincristine 12Bleomycin 11Interferon alpha-2 6Cyclophosphamide 6Methotrexate 5Liposomes 5Leucovorin 5Dexamethasone 5tecogalan 4sargramostim 4Filgrastim 4Etoposide 4Cytarabine 4Ritonavir 3Nivolumab 3Fluorouracil 3pomalidomide 2liposomal doxorubicin 2interferon alfa-n1 2Watchful Waiting 2Valganciclovir 2Tumor Necrosis Factor-alpha 2Tobacco Use Cessation Devices 2Thalidomide 2Surveys and Questionnaires 2Rituximab 2Paclitaxel 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acquired Immunodeficiency Syndrome × Rapid Diagnostic Tests × Clear all
NCT01790633 2016-12-13

OPTISCREEN-III

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

Phase NA Completed
327 enrolled 9 charts
Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡